Cargando…
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975067/ https://www.ncbi.nlm.nih.gov/pubmed/31969184 http://dx.doi.org/10.1186/s13058-019-1240-y |
| _version_ | 1783490228926808064 |
|---|---|
| author | Jacobs, Samuel A. Robidoux, André Abraham, Jame Pérez-Garcia, José Manuel La Verde, Nicla Orcutt, James M. Cazzaniga, Marina E. Piette, Fanny Antolín, Silvia Aguirre, Elena Cortes, Javier Llombart-Cussac, Antonio Di Cosimo, Serena Kim, Rim S. Feng, Huichen Lipchik, Corey Lucas, Peter C. Srinivasan, Ashok Wang, Ying Song, Nan Gavin, Patrick G. Balousek, April D. Paik, Soonmyung Allegra, Carmen J. Wolmark, Norman Pogue-Geile, Katherine L. |
| author_facet | Jacobs, Samuel A. Robidoux, André Abraham, Jame Pérez-Garcia, José Manuel La Verde, Nicla Orcutt, James M. Cazzaniga, Marina E. Piette, Fanny Antolín, Silvia Aguirre, Elena Cortes, Javier Llombart-Cussac, Antonio Di Cosimo, Serena Kim, Rim S. Feng, Huichen Lipchik, Corey Lucas, Peter C. Srinivasan, Ashok Wang, Ying Song, Nan Gavin, Patrick G. Balousek, April D. Paik, Soonmyung Allegra, Carmen J. Wolmark, Norman Pogue-Geile, Katherine L. |
| author_sort | Jacobs, Samuel A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6975067 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69750672020-01-28 Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer Jacobs, Samuel A. Robidoux, André Abraham, Jame Pérez-Garcia, José Manuel La Verde, Nicla Orcutt, James M. Cazzaniga, Marina E. Piette, Fanny Antolín, Silvia Aguirre, Elena Cortes, Javier Llombart-Cussac, Antonio Di Cosimo, Serena Kim, Rim S. Feng, Huichen Lipchik, Corey Lucas, Peter C. Srinivasan, Ashok Wang, Ying Song, Nan Gavin, Patrick G. Balousek, April D. Paik, Soonmyung Allegra, Carmen J. Wolmark, Norman Pogue-Geile, Katherine L. Breast Cancer Res Correction BioMed Central 2020-01-22 2020 /pmc/articles/PMC6975067/ /pubmed/31969184 http://dx.doi.org/10.1186/s13058-019-1240-y Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Jacobs, Samuel A. Robidoux, André Abraham, Jame Pérez-Garcia, José Manuel La Verde, Nicla Orcutt, James M. Cazzaniga, Marina E. Piette, Fanny Antolín, Silvia Aguirre, Elena Cortes, Javier Llombart-Cussac, Antonio Di Cosimo, Serena Kim, Rim S. Feng, Huichen Lipchik, Corey Lucas, Peter C. Srinivasan, Ashok Wang, Ying Song, Nan Gavin, Patrick G. Balousek, April D. Paik, Soonmyung Allegra, Carmen J. Wolmark, Norman Pogue-Geile, Katherine L. Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer |
| title | Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer |
| title_full | Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer |
| title_fullStr | Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer |
| title_full_unstemmed | Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer |
| title_short | Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer |
| title_sort | correction to: nsabp fb-7: a phase ii randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in her2+ breast cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975067/ https://www.ncbi.nlm.nih.gov/pubmed/31969184 http://dx.doi.org/10.1186/s13058-019-1240-y |
| work_keys_str_mv | AT jacobssamuela correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT robidouxandre correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT abrahamjame correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT perezgarciajosemanuel correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT laverdenicla correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT orcuttjamesm correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT cazzanigamarinae correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT piettefanny correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT antolinsilvia correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT aguirreelena correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT cortesjavier correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT llombartcussacantonio correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT dicosimoserena correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT kimrims correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT fenghuichen correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT lipchikcorey correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT lucaspeterc correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT srinivasanashok correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT wangying correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT songnan correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT gavinpatrickg correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT balousekaprild correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT paiksoonmyung correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT allegracarmenj correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT wolmarknorman correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer AT poguegeilekatherinel correctiontonsabpfb7aphaseiirandomizedneoadjuvanttrialwithpaclitaxeltrastuzumabandorneratinibfollowedbychemotherapyandpostoperativetrastuzumabinher2breastcancer |